Drug Profile
SDZ 272070
Alternative Names: SDZ-272070Latest Information Update: 13 Jun 2001
Price :
$50
*
At a glance
- Originator Novartis
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 13 Jun 2001 No-Development-Reported for Type-2 diabetes mellitus in Switzerland (Unknown route)
- 14 Jul 1998 Preclinical development for Type-2 diabetes mellitus in Switzerland (Unknown route)